ライフサイエンスコーパス: SD

1 SD selectively enhanced 5alphaR expression and activity,

2 SD-OCT and OCT-A, which have not been previously reporte

3 ed with the mean baseline TRS score of 57.0 (SD 10.2), the mean score at 6 months decreased to 40.1 (

4 er handwashes, and 1.8% (SD = 0.1%) to 7.0% (SD = 0.3%) (n = 3) for water-only.

5 rates range from 95.9% (SD = 0.1%) to 97.0% (SD = 2.5%) for soap-and-water handwashes, and 1.8% (SD =

6 ry feeding stage was associated with a 0.002-SD decrease in HAZ (P = 0.030).

7 uration of AAS use: 0.60 SD units [0.16-1.03 SD units]; P=0.008).

8 42% lower triglycerides (beta=-0.92+/-0.059 SD unit; P=9.6x10(-55) in 4668 Pimas and 2793 Southwest

9 8, -0.12], p < 0.001) than for whites (-0.09 SD/decade, 95% CI [-0.16, -0.02], p = 0.009).

10 gher risk of AF; the hazard ratio for each 1 SD lower SD of normal-to-normal RR intervals was 1.14 (9

11 a-media thickness (39%; 95% CI, 9%-77% per 1 SD).

12 Growing up in a county with 1 SD better intergenerational mobility accounts for approx

13 ration potentially traumatic events was 2.1 (SD 1.4).

14 Mean NDI-SF score of Whipple group was 23.1 (SD 8.88).

15 both presymptomatic (mean BOLD change 1.1% [SD 0.5], mean difference -0.4% change, 95% CI -0.7 to -0

16 disease, stroke, and CVD associated with a 1-SD decrease in mtDNA-CN were 1.29 (95% CI, 1.24-1.33), 1

17 ed that, at Y0, SBP (hazard ratio [HR] per 1-SD increase, 1.32; 95% CI, 1.09-1.61) but not DBP (HR, 1

18 Ketamine (mean 5.17, SD 2.92), when compared with saline (5.54, 3.42), had no

19 anaemic mothers in the MMN group scored 0.18 SD (0.06-0.31, p=0.0047) higher in general intellectual

20 cebo-associated improvement of less than 0.2 SD provides evidence that ceiling effects do not occur i

21 ems (defined as a Total Problem T score >/=2 SD above the mean on the Child Behavior Checklist).

22 as at least 1 standard score greater than 2 SD below the mean on the Wide Range Achievement Test-4),

23 max of the most active disease site was 9.2 (SD, 6.1).

24 relevant but statistically significant (0.2 [SD 1.1] vs 0.1 [1.1], p=0.010) difference between the tw

25 ne (p = 0.021) on the MMSE for Asians (-0.20 SD/decade, 95% CI [-0.28, -0.12], p < 0.001) than for wh

26 emory and cognitive processing speed by 0.21 SD (95% CI: -0.04, 0.46) and 0.28 SD (95% CI: 0.02, 0.54

27 ed by 0.21 SD (95% CI: -0.04, 0.46) and 0.28 SD (95% CI: 0.02, 0.54), respectively.

28 Given that the patients performed 2.28 SDs below normative standards on average at baseline, a

29 dard deviation, SD, 6.4) after VR, and 64.3 (SD, 11.7) after standard preoperative experience (differ

30 c change from baseline to 28 weeks was 0.3% (SD 0.9; 3.3 mmol/mol [SD 9.8]) in the CGM plus CSII grou

31 tion of PM1 in all cities was 42.5 mug/m(3) (SD 34.6) and of PM2.5 was 51.9 mug/m(3) (41.5).

32 omplete response, 0%; partial response, 33%; SD or DP, 67%) (P < .001).

33 weight children was large in the NCDS [-0.37 SD, 95% confidence interval (CI): -0.46, -0.27] and in t

34 136 randomized participants (mean age, 50.4 [SD, 13.3] years; 42% women), 113 (83%) completed the stu

35 Combined overall 3-year survival was 40.4% (SD 7.7%) in the open group versus 50.5% (SD 8%) in the m

36 symptomatic carriers (mean BOLD change 0.4% [SD 0.1], mean difference -0.9%, 95% CI -1.1 to -0.6; p<0

37 8 patients with baseline data (mean age, 47 [SD, 16.0] years; 63% women; 17% smokers; 77% phlegm; 70%

38 ls using z score analysis; RI values </= 2.5 SDs were considered abnormal.

39 in the average duration of treatment (27.5 [SD 21.5], 24.9 [17.7], 27.9 [16.8] weeks, respectively;

40 4% (SD 7.7%) in the open group versus 50.5% (SD 8%) in the minimally invasive group (P = 0.207).

41 d intention-to-treat analysis (mean age, 52 [SD, 14] years; 75 women [35%]).

42 ease in cumulative duration of AAS use: 0.60 SD units [0.16-1.03 SD units]; P=0.008).

43 at 23 to 24 weeks' gestation performed 0.66 SD (95% CI, -0.73 to -0.59) lower compared with those bo

44 d executive function (differences of 0.6-0.7 SD; P=1.2x10(-3)-2.4x10(-4)).

45 tiandrogenic activity equal to 45.5 (+/-13.7 SD) FEq/L.

46 oncentrations of 0.79% (SD, 0.24) and 0.76% (SD, 0.18), respectively.

47 tory and expiratory concentrations of 0.79% (SD, 0.24) and 0.76% (SD, 0.18), respectively.

48 5%) for soap-and-water handwashes, and 1.8% (SD = 0.1%) to 7.0% (SD = 0.3%) (n = 3) for water-only.

49 spent in the target glucose range was 59.8% (SD 18.7) in the closed-loop group and 38.1% (16.7) in th

50 Average BMI at surgery was 13.83 (SD 1.49) and 14 (88%) of the 16 patients had comorbid mo

51 s, mean DEHP removal rates range from 95.9% (SD = 0.1%) to 97.0% (SD = 2.5%) for soap-and-water handw

52 fruit, vegetable and legume intake was 3.91 (SD 2.77) servings per day.

53 was very high for both readers, AUC = 0.99 (SD = 0.05).

54 ics and 45.5% stroke, and younger (mean age (SD)) 49.1 (18.8) than medical mimic (63.5 years (16.7))

55 somnography, and in 14 older adults (age +/- SD: 62.3 +/- 1.3 years) without SDB (AHI < 5).

56 pocampal regions of 19 older adults (age +/- SD: 66.1 +/- 1.9 years) with moderate to severe SDB, def

57 41 patients (16 women, 25 men; mean age +/- SD, 48 +/- 14 y) with cerebral gliomas (World Health Org

58 ale, 84% non-Hispanic white, with mean age+/-SD 62+/-11 years; 16% (n=237) were cognitively impaired

59 Age-Related Eye Disease Study 2 Ancillary SD OCT study participants with age-related macular degen

60 genes and relevant pathways common to KT and SD.

61 ipants underwent 10-2 visual field tests and SD-OCT scans, and all participants completed the 25-item

62 on in all children, with an overall average (SD) of 98.2 x 10(5) (29.8 x 10(5)) particles/ml.

63 Baseline variability in controls (SD of SUVr and DeltaSUVr) and effect sizes for group dif

64 ypoglycemic on CGM were unchanged with CSII, SD glucose and CONGA4 reduced significantly (P < 0.05).

65 latively invariant across sites (mean CV +/- SD = 0.04 +/- 0.01; 7-20 sites in each of 10 neurons), w

66 -7.63 D [SD 3.31]) and CACNA1F (SE -5.33 D [SD 3.10]) coincided with the highest degree of myopia an

67 Mutations in RPGR (SE -7.63 D [SD 3.31]) and CACNA1F (SE -5.33 D [SD 3.10]) coincided w

68 st degree of myopia and in CABP4 (SE 4.81 D [SD 0.35]) with the highest degree of hyperopia.

69 oyang (GMFS) in healthy male Sprague Dawley (SD) rats.

70 numbers of days of sick leave were 3.4 days (SD 7.1) in the resection group versus 1.4 days (4.7) in

71 n sound levels were 78 dB (SD, 9) and 62 dB (SD, 8), respectively.

72 Maximum and mean sound levels were 78 dB (SD, 9) and 62 dB (SD, 8), respectively.

73 d patients in hemorrhagic shock demonstrated SD physiology on admission.

74 p/wake parameters, mice were sleep deprived (SD) for 6 h.

75 A 1 standard deviation (SD) increase in VO2Max was associated with better scores

76 patients was 60.7 years (standard deviation [SD] 13.2 years).

77 g performance that was 1 standard deviation [SD] above the hospital mean) and 30-day risk-standardize

78 ge (mean age, 9.4 years; standard deviation [SD], 4.56 years) with glaucoma and their parents.

79 e EVAN-G score was 84.3 (standard deviation, SD, 6.4) after VR, and 64.3 (SD, 11.7) after standard pr

80 5% calorie restricted (CR) or standard diet (SD).

81 The standardized difference (SD) in cognitive scores between low-birth-weight and nor

82 49%; partial response, 38%; stable disease [SD] or local disease progression [DP], 13%) versus 33% o

83 ex thickness as measured by spectral-domain (SD) optical coherence tomography (OCT).

84 This study compares EDI SD OCT-determined morphologic characteristics of drusen

85 17, -0.89]), and apolipoprotein B (change in SD units [95% confidence interval]: -0.98 [-1.11, -0.86]

86 w-density lipoprotein cholesterol (change in SD units [95% confidence interval]: -1.01 [-1.14, -0.88]

87 .14, -0.88]), remnant cholesterol (change in SD units [95% confidence interval]: -1.03 [-1.17, -0.89]

88 , HR, RBF, or creatinine clearance (CrCl) in SD rats (n = 7).

89 ver the observed growth rate distribution in SD medium.

90 attenuated by progesterone (30 mg/kg, IP) in SD-subjected, but not control rats.

91 of AF; the hazard ratio for each 1 SD lower SD of normal-to-normal RR intervals was 1.14 (95% confid

92 Mean (SD) baseline deseasonalized 25(OH)D concentration was 26

93 Mean (SD) Dermatology Life Quality Index and Chronic Urticaria

94 Mean (SD) patient age was 62.1 (20.3) years for ambulatory vs

95 Mean (SD) time to recurrence after MMS was 3.91 (4.4) years, a

96 Mean (SD) total ophthalmologist time spent using the EHR was 1

97 5% CI, 0.21-3.05]; effect size, 0.21), mean (SD) total SAC-C score (boys, 23.9 [3.9] vs girls, 24.9 [

98 5% CI, 1.60-5.02]; effect size, 0.35), mean (SD) number and severity of symptoms reported by the pare

99 (62 boys [59.6%] and 42 girls [40.4%]; mean (SD) age, 9.9 [1.5] years), the adjusted median number of

100 The cohort had a mean (SD) age of 44.6 (11.9) years and was predominately femal

101 ort comprised 16391 men (71.9%), had a mean (SD) age of 69.1 (11.5) years, and was predominantly whit

102 00 comprised 143 men (47.7%) and had a mean (SD) age of 78.6 (11.5) years.

103 After a mean (SD) follow-up of 6.4 (2.5) years, RV outflow tract dimen

104 injection initiation, these eyes had a mean (SD) loss of 11.0 (10.1) (VISTA) and 10.0 (6.5) (VIVID) l

105 lower-level baseline symptoms, with a mean (SD) of 0.39 (0.84) elevations among PSE participants com

106 and enrolled in a follow-up substudy a mean (SD) of 10 (3) months after the initial study closeout.

107 seline, and they subsequently gained a mean (SD) of 17.4 (9.7) (VISTA) and 13.6 (8.6) (VIVID) letters

108 while the DRCR.net participants were a mean (SD) of 65.5 (9.3) years of age, 44.1% women, and 76.3% w

109 witching, the CATT participants were a mean (SD) of 79.7 (7.8) years of age, 65.9% women, and 97.6% w

110 care plus coaching group, the adjusted mean (SD) BMI z score was 1.87 (0.56) at baseline and 1.79 (0.

111 participants [n = 70, 45 females; age mean (SD) = 22.12 (2.16)] during a declarative memory task.

112 he analysis, 209 (67.6%) were men, and mean (SD) age was 64.6 (10.1) years.

113 61 to -0.23]; effect size, -0.25), and mean (SD) mBESS score (boys, 1.21 [1.5] vs girls, 0.71 [1.0];

114 3.0 mum in VIVID), after which further mean (SD) reductions of 285.6 (202.6) mum (VISTA) and 313.4 (1

115 considerably different between groups: mean (SD) vessel density of the deep retinal capillary plexus

116 sis-associated uveitis had the highest mean (SD) serum sIL-2R (6047 [2533] pg/mL) and ACE (61 [38] U/

117 f the lateral temporal lobe, and lower mean (SD) cerebrospinal fluid levels of tau (59.2 [32.8] vs 11

118 Among 112 study participants with MCI, mean (SD) age was 76.6 (6.9) years, 55 were women (49.1%), and

119 patients enrolled, 12 (71%) were men; mean (SD) age was 45.2 (14.6) years.

120 In total, 12428 patients (mean (SD) age at cancer diagnosis, 75 (7) years; 52.0% female)

121 The mean (SD) age at diagnosis for the 65 057 women included in th

122 The mean (SD) age at end of follow-up was 4.6 (0.40) years for the

123 is series (28 female and 15 male), the mean (SD) age at examination was 2.1 (1.5) months.

124 The mean (SD) age of participants was 13.2 (2.6) years; of the 115

125 The mean (SD) age of patients was 62.1 (13.8) years, and 636 (52.9

126 The mean (SD) age of the participants at the antenatal interview w

127 The mean (SD) age of the participants was 40.93 (13.5) years; most

128 84 (23.3%) men at the study start; the mean (SD) age of these patients was 27.8 (10.1) years at the s

129 ients with TOF, 57% were male, and the mean (SD) age was 31 (11) years.

130 The mean (SD) age was 34.6 (45.2) months in the craniosynostosis c

131 atients with TNBC, all were women; the mean (SD) age was 48 (11) years.

132 went MAG, 586 (11%) were women and the mean (SD) age was 60 (8.7) years.

133 Of the participants, the mean (SD) age was 60.7 (13.9) years and 249 participants (3.6%

134 men (44.2%) and women (55.8%), and the mean (SD) age was 66.3 (6.1) years.

135 ITA+SVG, 2803 (19%) were women and the mean (SD) age was 68 (8.9) years.

136 cs, 16 were women and 15 were men; the mean (SD) age was 69 (10) years.

137 In the study cohort, the mean (SD) age was 69.6 (12.1) years among 1105356 patients (40

138 half were male and all were white; the mean (SD) age was 69.7 (14.1) years.

139 Among the 138 men, the mean (SD) age was 71.2 (5.7) years, and 81% were white.

140 rolled; 233 (52.2%) were male, and the mean (SD) age was 71.5 (9.9) years.

141 g the 1727 patients with late AMD, the mean (SD) age was 78.7 (7.4) years, and 668 (38.7%) were men.

142 The mean (SD) CAP and median (IQR) LS values at baseline were 249.

143 ] years; 8516 men and 6016 women), the mean (SD) endothelial cell count was 2732 (437) cells/mm2.

144 %]) contributed 390 eyes for which the mean (SD) follow-up time was 3.9 (1.6) years (range, 0.7-12.1

145 The mean (SD) GPBB levels were higher in cases (46.3+/-38.6 ng/mL

146 The mean (SD) IE count was 1325 (1093) IE/kg.

147 1 disc diameter from optic nerve), the mean (SD) largest basal diameter was 18.1 (1.9) mm and mean he

148 The mean (SD) length of follow-up was 40.8 (22.2) months.

149 Sex had a small effect on the mean (SD) number and severity of symptoms reported by the chil

150 The mean (SD) rate of decline in FEV1 was 39.0 (58.6) ml/yr.

151 The mean (SD) result of the Dresdner correction formula (17.6 [4.1

152 The mean (SD) SMR was 0.46 (1.06) vs 0.50 (1.50) events per year i

153 The mean (SD) time to symptom resolution was 13.8 (5.8) days in th

154 en and 4575898 (66.2%) were men; their mean (SD) age was 64.5 (12.3) years.

155 ses were included in this study; their mean (SD) age was 66.5 (17.6) years, and a total of 465 (58%)

156 MDS-UPDRS Part I total mean (SD) scores increased from baseline 5.6 (4.1) to 7.7 (5.0

157 tion study), 45 were women (56%), with mean (SD) age, 38.4 (10.2) years.

158 vs 13 patients for the WLE group, with mean (SD) survival of 6.5 (4.8) and 6.1 (0.8) years, respectiv

159 participants, 931 [45.5%] were women; mean (SD) age at first assessment was 62.56 (14.63) years.

160 ore severe glaucoma had higher (worse) mean (SD) scores than those with mild glaucoma at baseline on

161 the patients was 18-45 years with a mean (+/-SD) of 27.6+/-7.607 years, while that of the controls wa

162 the controls was 21-43 years with a mean (+/-SD) of 28.0+/-5.079 years (p=0.746).

163 ned in all the participants, with a mean (+/-SD) steady-state factor IX coagulant activity of 33.7+/-

164 Mean +/- SD patient age was 60 +/- 10 years; most patients were m

165 (123)I-MIBG injection (191 +/- 41 [mean +/- SD] MBq).

166 ort genes, decreased by 43% +/- 5% (mean +/- SD).

167 ssments in 161 children; boys: 61%; mean +/- SD recruitment age: 2.8 +/- 0.9 y; GMFCS: I, 48%; II, 11

168 Baseline PETco2 was 38.9 +/- 0.8 (mean +/- SD) mm Hg (range, 35-43 mm Hg).

169 ocalized civil conflict fatalities (mean +/- SD: 1.41 +/- 10.21 fatalities) for children living in ru

170 group than in the midazolam group (mean +/- SD, 205 +/- 56 vs. 166 +/- 59, respectively; P = 0.04).

171 the intervention and control group (mean +/- SD: -0.23 +/- 0.56 compared with -0.20 +/- 0.49 kg/m(2))

172 ere employed before ARDS (56% male; mean +/- SD age, 45 +/- 13 yr), with seven dying by 12-month foll

173 ohort of 687 stable RTRs (57% male; mean +/- SD age: 53 +/- 13 y) with a median (IQR) follow-up of 5.

174 of in vivo MRI scans (N = 51 males, mean +/- SD 24.1 +/- 3.1 years of age) showed similar sulci patte

175 h BCR of PCa, who were 59-83 y old (mean +/- SD, 68.7 +/- 6.4 y).

176 graphy-tandem mass spectrometry.The mean +/- SD 25(OH)D3 concentration for all subjects was 27.7 +/-

177 The mean +/- SD birth weight was 3160 +/- 770 g in the enteral tube f

178 (PCI), and norepinephrine dose, the mean +/- SD post-arrival incremental change of the ln-transformed

179 The mean +/- SD vegetable nitrate intake was 67.0 +/- 29.2 mg/d.

180 ly teams showed less hands-on time (mean +/- SD) (87 +/- 41 vs 109 +/- 33 s; p = 0.037) and a longer

181 volunteers [150 men and 155 women; mean +/- SD age: 25 +/- 6 y; body mass index (BMI; in kg/m(2)): 2

182 MS for an average of 7.9 +/- 4.3 y (mean +/- SD), their total relapses averaged 4 +/- 2.4, and their

183 034 men [84.0%] and 386 women [16.0%]; mean [SD] age, 54.7 [12.2] years) (898 in the preimplementatio

184 , 54 patients with cellulitis (n = 23; mean [SD] age, 57.2 [17.7] years) or necrotizing fasciitis (n

185 ars) or necrotizing fasciitis (n = 31; mean [SD] age, 54.3 [13.5]) were included in this study.

186 A total of 9713 patients (36%; mean [SD] age, 46.9 [11.3] years; 16.6% male) achieved a BMI o

187 ipants (87 men [93%] and 7 women [7%]; mean [SD] age, 34 [8] years), global disability, satisfaction

188 (64 men [59.3%] and 44 women [40.7%]; mean [SD] age, 62.0 [12.7] years) admitted to the SICU, 53 wer

189 6.1%) and 4 affected relatives (2.8%) (mean [SD] age, 24.1 [6.1] years; 11 male and 16 female) presen

190 6 female [65.1%] and 202 male [34.9%]; mean [SD] age, 33.2 [17.1] years) from 13 cohorts in 6 countri

191 ained or improved their visual acuity (mean [SD], +3.8 [9.6] letters).

192 Of the 43249 patients with AML (mean [SD] age, 59.5 [16.6] years; 23939 men and 19310 women),

193 the 2654 women in the final analysis (mean [SD] age, 31.0 [5.7] years), most were non-Hispanic white

194 ly), and strength of the associations (mean [SD], 1.6 [0.3] and 1.5 [0.3] respectively) among flashba

195 led in the 8th or 9th grade (baseline; mean [SD] age, 14.4 [0.7] years).

196 o increased costs from room and board (mean [SD] cost, MP $11940 [MP $8820]), consultations (mean [SD

197 reterm children (19 girls and 33 boys; mean [SD] age at examination, 6.6 [0.1] years) and 45 children

198 en born at term (22 girls and 23 boys; mean [SD] age at examination, 6.6 [0.1] years).

199 in the study (195 girls and 220 boys; mean [SD] age, 363.0 [8.3] days), a consistent association bet

200 $2410]), and intensive care unit care (mean [SD] cost, MP $7770 [MP $14310]).

201 MP $11940 [MP $8820]), consultations (mean [SD] cost, MP $3530 [MP $2410]), and intensive care unit

202 [63% female]) and 24 healthy controls (mean [SD] age, 32.2 [12.0] years; 13 [54% female]).

203 pes and CAD were younger at diagnosis (mean [SD] age, 40.7 [3.5] vs 58.1 [2.5] years; P < .

204 Among 14532 donors (mean [SD] age, 58.6 [13.4] years; 8516 men and 6016 women), th

205 s with first episodes of endocarditis (mean [SD] age, 62.3 [18.9] years; 59.1% male), the standardize

206 60 were eligible and 78 were enrolled (mean [SD] age, 16.5 [0.73] years), of whom 2 (3%) were Asian/P

207 1 [35.9%] male and 413 [64.1%] female; mean [SD] age, 69.4 [6.1] years; 611 white [94.9%]) seen by 31

208 62 patients (43 males and 19 females; mean [SD] age at biopsy, 61.6 [13.7] years), 89.9% (124 of 138

209 hen f = 0.28), and better functioning (mean [SD], 68.5 [10.7] vs 61.9 [11.9]; t156 = 3.64; P < .001;

210 d across 2 equally distributed groups (mean [SD] age, 62.25 [13.92] years for cases and 58.32 [14.79]

211 characterized in 30 patients with HS (mean [SD] age, 46.9 [14.0] years; 19 [63% female]) and 24 heal

212 from the Mainsail trial were included (mean [SD] age, 68.7 [7.89] years).

213 A total of 152 participants (72% male; mean [SD] FEV1 percent predicted, 50.5% [21.2]; median [first

214 luded in the study (26997 [80.0%] men; mean [SD] age, 32.9 [13.3] years), 18338 (54.3%) received an o

215 participants (3342 women and 4480 men; mean [SD] age, 40.1 [10.7] years), the median comorbid criteri

216 3 patients (12822 women and 17001 men; mean [SD] age, 44.9 [12.0] years).

217 nsplant group (27.3% women; 72.7% men; mean [SD] age, 57.5 [11.1] years) were identified who were hos

218 non-CKD group (34.7% women; 65.3% men; mean [SD] age, 64.2 [14.4] years), 30072 patients in the stage

219 5D CKD group (45.0% women; 55.0% men; mean [SD] age, 66.9 [12.5] years), and 2980 patients in the re

220 ients with MCI (225 women and 297 men; mean [SD] age, 72.6 [7.8] years).

221 al individuals (135 women and 130 men; mean [SD] age, 75.5 [6.7] years) and 522 patients with MCI (22

222 patients (204232 women and 252961 men; mean [SD] age, 76.3 [6.9] years) during which a PAC was placed

223 ile 107 patients (57 women and 50 men; mean [SD] age, 83.3 [13.5] years) underwent NASH FibroSure tes

224 ion of temporoparietal FDG metabolism (mean [SD] FDG: Abeta-N+, 1.25 [0.11] vs Abeta+N+, 1.19 [0.11])

225 54 (56%) of the NeoALTTO participants (mean [SD] age of substudy participants, 48.8 [11.2] years).

226 s than in noncarriers in participants (mean [SD], 1.66 [0.41] vs 1.43 [0.15]) compared with controls

227 articipants and 101 male participants; mean [SD] age, 33.0 [15.1] years) had areas of DDAF present on

228 The 217 patients (mean [SD] age, 21.8 [13.3] years; 127 female [57.5%]; 148 whit

229 The cohort included 345 patients (mean [SD] age, 69.9 [14.4] years in the stoma group and 70.9 [

230 Of the 2612 study patients (mean [SD] age, 74.6 [4.8] years; 1542 [59.0%] female), 424 had

231 was more expensive in these patients (mean [SD] cost, MP $8970 [MP $2750]) but was a smaller contrib

232 dysfunction developed in 85 patients (mean [SD] time from diagnosis, 6.7 [7.7] years) and was associ

233 t least 18 months after the procedure (mean [SD] follow-up, 33 [14] months).

234 Of the 721 patients randomized (mean [SD] age, 61.4 [10.5] years; 53.1% male), 580 (80.4%) com

235 the 925 patients who were randomized (mean [SD] age, 9.7 [5.3] years; 575 males [62%]), all complete

236 n and adolescents who were randomized (mean [SD] age, 9.8 [3.2] years; 38% female; 181 in IPM plus pe

237 oup and the placebo group was similar (mean [SD] change in weight-for-age z score: +0.14 [0.83] and +

238 Of the 65 women in the study (mean [SD] age, 47.7 [13.4] years), 32 (49%) were in the mobile

239 , 2598 births to AYA cancer survivors (mean [SD] maternal age, 31 [5] years) were included.

240 ctively), closeness to other symptoms (mean [SD], 0.9 [0.3] and 1.1 [0.9], respectively), and strengt

241 ich they occur between other symptoms (mean [SD], 1.2 [0.7] and 1.0 [0.9], respectively), closeness t

242 A total of 457317 women (mean [SD] age, 39.8 [12.5] years) with a screening test were r

243 Of the 7685 women (mean [SD] age, 40.0 [5.3] years) who met the inclusion criteri

244 Among the 42346 women (mean [SD] age, 53 [10] years), 65.3% (27654) were white, 12.7%

245 Of the 647 treated women (mean [SD] age, 55.0 [10.8] years), 614 had tumor tissue sample

246 egative patients (29 men and 11 women; mean [SD] age, 51 [9.9] years) demonstrated tumor cell PD-L1 e

247 ded in the study (26 men and 64 women; mean [SD] age, 55 [15] years), 32 (36%) had PDs on sEEG and dE

248 nts with glaucoma (7 men and 14 women; mean [SD] age, 63.7 [9.9] years) and 20 eyes from 20 healthy c

249 res (among 223877 men and 13080 women; mean [SD] age, 64.0 [11.3] years) from high-volume surgical sp

250 ntrol individuals (9 men and 11 women; mean [SD] age, 68.3 [10.7] years) were studied.

251 atients with cSCC (19 men and 5 women; mean [SD] age, 76.4 [12.2] years) detected increased PD-1 and

252 or AMD were followed up after 6 years (mean [SD] age, 60.7 [8.2] years; 635 female [49.5%]; 799 Kikuy

253 At baseline, mean+/-SD carotid IMT was significantly greater for the 197 chi

254 samples of quinoa, and found that the mean+/-SD content of AR was 58+/-16mug/g, bcAR was 182+/-52mug/

255 data.A total of 153 participants (means +/- SDs: BMI: 33.3 +/- 4.6; age: 63.8 +/- 6.3 y; 83% women)

256 The means +/- SDs of femoral neck BMD loss were -0.02 +/- 0.05 and 0.0

257 Similar means, SDs, and stunting rates were found when less restrictive

258 Mean ICP in supine was 10.3 mmHg (SD = 2.7) in the NTG group (n = 13) and 11.3 (2.2) mmHg

259 ce in 24-hour UFC excretion: 6.91 nmol/mmol (SD, 4.67 nmol/mmol) versus 7.58 nmol/mmol (SD, 6.17 nmol

260 (SD, 4.67 nmol/mmol) versus 7.58 nmol/mmol (SD, 6.17 nmol/mmol), with a mean difference of 0.67 nmol

261 to 28 weeks was 0.3% (SD 0.9; 3.3 mmol/mol [SD 9.8]) in the CGM plus CSII group and 0.1% (0.4; 1.1 m

262 The mean blood eosinophil count was 200/muL (SD, 144/muL).

263 f psychosis- and mania-like complications of SD through imbalances in cortical levels of neuroactive

264 We sought to evaluate the influence of SD on allergen-induced pulmonary inflammation.

265 e been identified during photodegradation of SDs, whereas a new pathway yielding oxidation of the ben

266 , multivariable adjusted risk ratios per one-SD higher log miR-122 were 1.60 (95% CI 1.30-1.96; P < 0

267 %) decrease in the odds of healthy aging per SD (0.062 m) increase in height.

268 th an increased risk of all dementia (HR per SD increase = 1.11 [1.03-1.19], p = 0.0044) and mixed or

269 d ratios (HRs) for incident parkinsonism per SD decrease in global cognition, adjusted for age, sex,

270 diovascular disease events (hazard ratio per SD increment, 1.38; 95% confidence interval, 1.15-1.66;

271 uous variables, and results are reported per SD increase of each lipid fraction.

272 uage treatment (mean difference 2.61 points [SD 4.94]; 95% CI 1.49 to 3.72), but not from baseline to

273 es of self-harm: self-injury alone pound753 (SD 2061), self-poisoning alone pound806 (SD 1568), self-

274 53 (SD 2061), self-poisoning alone pound806 (SD 1568), self-poisoning and self-injury pound987 (SD 18

275 8), self-poisoning and self-injury pound987 (SD 1823; p<0.0001).

276 unced correlation between weakened predicted SD-aSD interactions and reduced translation efficiency.

277 -0.2; p=0.001; mean time to baseline 10.1 s [SD 7.6], mean difference 4.6 s, 95% CI 0.4 to 8.8; p=0.0

278 0.6; p<0.0001; mean time to baseline 20.3 s [SD 8.4], mean difference 13.1 s, 95% CI 9.4 to 16.9; p<0

279 quantified reliably using eye-tracked serial SD OCT.

280 ts of these cell lines at a threshold of six SDs from the mean.

281 y (FA) and OCT was determined for structural SD-OCT alone, en face OCTA alone, and with en face OCTA

282 Poor response to DEB-TACE (SD or DP) was present in 86% of cases and accounted for

283 The SD of mean percentage change between test and retest usi

284 The SD-OCT measures had high intereye agreement (intraclass

285 The area of EZ loss was calculated from the SD-OCT and the area of retinal pigment epithelium (RPE)

286 pectral-domain optical coherence tomography (SD OCT) and the correlation to visual acuity (VA).

287 pectral-domain optical coherence tomography (SD-OCT) and short wavelength fundus autofluorescence (SW

288 pectral-domain optical coherence tomography (SD-OCT), and optical coherence tomography angiography (O

289 pectral-domain optical coherence tomography (SD-OCT), best-corrected visual acuity (BCVA), and microp

290 pectral domain optical coherence tomography (SD-OCT), supervised automated segmentation of individual

291 asuring the amplitude of the deepest S wave (SD) in any single lead and adding it to the S wave ampli

292 s and accounted for 35% of all patients with SD or DP (P < .001).

293 parts in the general population [29.1 years (SD 0.1) vs 65.4 years (0.1)], and thus spent less time i

294 hs apart) and ending at mean age 35.1 years (SD 0.6; wave 10).

295 A, and followed for an average of 3.4 years (SD 3.1 years).

296 participants with a mean age of 55.6 years (SD 9.7), 59.5% of whom were women.

297 Mean age was 77.7 years (SD 9.7) and 173 (68%) of 253 patients had moderate-to-se

298 ollow-up, commencing at mean age 15.9 years (SD 0.5; waves 3-6 during adolescence, 6 months apart) an

299 477 randomized patients (mean age, 44 years [SD, 15]; women, 274 [57%]; median time from orthopedic i

300 r atrial fibrillation (mean age, 74.7 years [SD, 10.8]; men, 55.8%; NOAC dabigatran, 45347 patients;